학술논문
Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Document Type
Article
Author
Rubinstein, P.G.; DeMarco, C.E.; Moore, P.C.; Bimali, M.; Lee, J.Y.; Rudek, M.A.; Ambinder, R.F.; Chadburn, A.; Cesarman, E.; Noy, A.; Ratner, L.; Henry, D.H.; Costagliola, D.; Taoufik, Y.; Ramos, J.C.; Sharon, E.; Mitsuyasu, R.; Reid, E.G.; Mounier, N.; Besson, C.; Barta, S.K.; Hamdan, A.; Boué, F.; Delobel, P.; Galicier, L.; Coppo, P.; Ghesquières, H.
Source
In: The Lancet Haematology . (The Lancet Haematology, August 2023, 10(8):e624-e632)
Subject
Language
English
ISSN
23523026